Why is IDEXX Laboratories, Inc. ?
1
High Management Efficiency with a high ROCE of 54.00%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.75 times
3
Healthy long term growth as Operating profit has grown by an annual rate 14.53%
4
Flat results in Dec 25
- INTEREST(9M) At USD 34.31 MM has Grown at 27.51%
5
With ROCE of 60.03%, it has a fair valuation with a 26.49 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 32.13%, its profits have risen by 19.4% ; the PEG ratio of the company is 2.5
6
High Institutional Holdings at 96.26%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
7
Market Beating Performance
- The stock has generated a return of 32.13% in the last 1 year, much higher than market (S&P 500) returns of 11.87%
How much should you hold?
- Overall Portfolio exposure to IDEXX Laboratories, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is IDEXX Laboratories, Inc. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
IDEXX Laboratories, Inc.
30.95%
0.22
43.81%
S&P 500
29.12%
0.62
19.30%
Quality key factors
Factor
Value
Sales Growth (5y)
9.72%
EBIT Growth (5y)
14.53%
EBIT to Interest (avg)
26.58
Debt to EBITDA (avg)
0.75
Net Debt to Equity (avg)
0.55
Sales to Capital Employed (avg)
1.57
Tax Ratio
20.41%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
96.26%
ROCE (avg)
54.00%
ROE (avg)
82.05%
Valuation Key Factors 
Factor
Value
P/E Ratio
56
Industry P/E
Price to Book Value
37.09
EV to EBIT
44.13
EV to EBITDA
40.93
EV to Capital Employed
26.49
EV to Sales
13.99
PEG Ratio
2.51
Dividend Yield
NA
ROCE (Latest)
60.03%
ROE (Latest)
65.92%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Mildly Bearish
Technical Movement
5What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 1,178.06 MM
RAW MATERIAL COST(Y)
Fallen by -1.66% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 4.31 times
-3What is not working for the Company
INTEREST(9M)
At USD 34.31 MM has Grown at 27.51%
Here's what is working for IDEXX Laboratories, Inc.
Operating Cash Flow
Highest at USD 1,178.06 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Inventory Turnover Ratio
Highest at 4.31 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -1.66% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at USD 38.72 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for IDEXX Laboratories, Inc.
Interest
At USD 34.31 MM has Grown at 27.51%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)






